<i>Saccharomyces boulardii</i> CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review.

Clin Med Insights Gastroenterol · 2018 · PMC5808955 · PMID 29449779

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

boulardii CNCM I-745 (0.8 [SD: 2.4] days) than with miglustat plus placebo (1.3 [SD: 2.4] days), as a statistical trend (no significance) in favour of the S. boulardii CNCM I-745 treatment. 43 Also, other yeast-derived saccharidase activities have been found: treatment of growing rats with S. boulardii CNCM I-745 resulted in an increase in α,α-trehalase activities of 25% to 45% in filtered endoluminal fluid and inte

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.